Novartis and Alnylam recently collaborated to leverage proprietary siRNA technology to develop liver-targeted therapy as an alternative to transplantation for patients experiencing liver...
Life Science Biosensor Diagnostics (LSBD), a subsidiary of the iQ Group Global, recently filed an FDA Breakthrough Device Designation application for its Saliva Glucose Biosensor for diabetes care...
FDA recently granted emergency use authorization to Roche’s COVID-19 At-Home Test for children aged 14 years and older and by an adult for children aged two to 13 years.
The COVID-19 At-Home...
Moderna recently announced that its COVID-19 vaccine booster increased neutralizing activity levels against the Omicron variant.
The currently authorized 50-microgram booster of mRNA-1273...
Kite, a Gilead Company, recently announced positive primary results from a Phase 2 study of Yescarta in patients with high-risk large B-cell lymphoma (LBCL).
The global ZUMA-12 study enrolled 42...
Johnson & Johnson recently announced longer-term results from the Phase 1b/2 study evaluating the safety and efficacy of its T-cell (CAR-T) therapy for patients with relapsed or refractory multiple...
Pfizer recently entered into a $6.7 billion proposed pharma acquisition deal with Arena Pharmaceuticals to develop therapies for chronic disease management.
Arena Pharmaceutical’s...
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recently issued positive opinion of Johnson & Johnson’s COVID-19 vaccine booster for...
Roche recently launched the AVENIO Edge System to advance next-generation sequencing (NGS) technologies.
Researchers can use the pre-analytical program for sequencing library preparation, target...
Pfizer and BioNTech recently announced that their COVID-19 vaccine neutralized the SARS-CoV-2 Omicron variant after three doses.
A month after receiving the booster vaccination, sera obtained...
GSK and the University of Oxford recently entered into a five-year collaboration to improve the success and speed of research and development of new medicines and unravel mechanisms of disease.
GSK...
GSK recently launched an international, multi-year initiative to advance innovation and address key needs in the multiple myeloma community.
The project, Target the Future, will provide education on...
FDA recently approved imaging drug Cytalux to assist surgeons in identifying ovarian cancer lesions.
Cytalux is approved for use in adult patients with ovarian cancer to help identify...
AstraZeneca recently unveiled a $1 billion state-of-the-art research and development facility to advance next-generation therapeutics, including nucleotide-based gene-editing and cell therapies.
The...
Specialty drugs accounted for 51.4 percent of the net cost in Medicaid and 1.3 percent of utilization in 2020, according to a Magellan Health trend report.
The Medicaid Pharmacy Trend Report looked at...
Moderna recently announced that its mRNA therapeutic for heart failure patients undergoing coronary artery bypass grafting (CABG) surgery met its primary endpoint in a Phase 2 study.
The...
Bristol Myers Squibb recently announced that Opdivo plus chemotherapy significantly improved event-free survival (EFS) in patients with resectable stage IB to IIIA non-small cell lung cancer...
Roche recently launched the AVENIO Tumor Tissue CGP Kit, a genomic profiling kit to allow laboratories to expand their oncology research in-house.
AVENIO Tumor Tissue CGP Kit is a...
FDA recently granted emergency use authorization to Thermo Fisher Scientific to run new saliva sample collection methods on its COVID-19 tests.
The company’s molecular diagnostics Spectrum...
FDA recently accepted Novartis’ biologics license application for Beovu, the company’s diabetic macular edema (DME) drug.
Specifically, FDA accepted the application for six...
